Clinical trial
Effects of Sodium Tanshinone IIA Sulfonate on Left Ventricular Remodeling in Patients With ST-segment Elevation Myocardial Infarction Following Percutaneous Coronary Intervention
NCT02524964 is registered in ClinicalTrials.gov with Guangdong Provincial Hospital of Traditional Chinese Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of Sodium Tanshinone IIA Sulfonate on Left Ventricular Remodeling in Patients With ST-segment Elevation Myocardial Infarction Following Percutaneous Coronary Intervention
- Lead sponsor
- Guangdong Provincial Hospital of Traditional Chinese Medicine
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- December 31, 2015
- Completion date
- July 31, 2017
- Enrollment
- 60 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute myocardial infarction, left ventricular remodeling